Illumina (ILU) Stock Forecast, Price Targets and Analysts Predictions

ILU Analyst Ratings

Moderate Buy

7 Buy

3 Hold

3 Sell

Based on 13 analysts giving stock ratings to

Illumina

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

ILU Stock 12 Month Forecast

Average Price Target

$124.29

Based on 13 Wall Street analysts offering 12 month price targets for Illumina in the last 3 months. The average price target is $124.29 with a high forecast of $161.98 and a low forecast of $76.94. The average price target represents a ― change from the last price of ―.

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

Highest Price Target$161.98

Average Price Target$124.29

Lowest Price Target$76.94

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Subbu Nambi

Guggenheim

CHF145.78→CHF161.98

Buy

―

Reiterated

06/29/26

Illumina price target raised to $200 from $180 at GuggenheimIllumina price target raised to $200 from $180 at Guggenheim

Eve Burstein

Bernstein

CHF149.83

Hold

―

Initiated

06/25/26

Illumina resumed with a Market Perform at BernsteinIllumina resumed with a Market Perform at Bernstein

Luke Sergott

Barclays

CHF98.81→CHF117.44

Sell

―

Assigned

06/24/26

Barclays Sticks to Their Sell Rating for Illumina (ILMN)

Casey Woodring

J.P. Morgan

CHF101.24→CHF149.83

Buy

―

Upgraded

06/10/26

Illumina upgraded to Overweight from Neutral at JPMorganIllumina upgraded to Overweight from Neutral at JPMorgan

Dan Leonard

RBC Capital

CHF137.68

Buy

―

Initiated

05/14/26

Illumina resumed with an Outperform at RBC CapitalIllumina resumed with an Outperform at RBC Capital

Michael Ryskin

Bank of America Securities

CHF68.84→CHF80.99

Sell

―

Reiterated

05/14/26

Bank of America Securities Sticks to Its Sell Rating for Illumina (ILMN)

Narumi Nakagiri

Daiwa

CHF125.53

Buy

―

Upgraded

05/14/26

Illumina upgraded to Outperform from Neutral at DaiwaIllumina upgraded to Outperform from Neutral at Daiwa

Patrick B Donnelly

Citi

CHF64.79→CHF76.94

Sell

―

Assigned

05/04/26

Illumina price target raised to $95 from $80 at CitiIllumina price target raised to $95 from $80 at Citi

David Westenberg

Piper Sandler

CHF137.68

Buy

―

Reiterated

05/01/26

Illumina (ILMN) Receives a Buy from Piper Sandler

Kyle Mikson CFA

Canaccord Genuity

CHF121.49→CHF113.39

Hold

―

Reiterated

05/01/26

Illumina price target lowered to $140 from $150 at CanaccordIllumina price target lowered to $140 from $150 at Canaccord

Daniel Arias

Stifel Nicolaus

CHF125.53

Buy

―

Reiterated

05/01/26

Stifel Nicolaus Keeps Their Buy Rating on Illumina (ILMN)

Vijay Kumar

Evercore ISI

CHF121.49→CHF125.53

Buy

―

Reiterated

05/01/26

Illumina price target raised to $155 from $150 at Evercore ISIIllumina price target raised to $155 from $150 at Evercore ISI

Daniel Brennan

TD Cowen

CHF95.3→CHF113.39

Hold

―

Reiterated

04/30/26

Analysts Offer Insights on Healthcare Companies: Illumina (NASDAQ: ILMN) and Cardinal Health (NYSE: CAH)

Catherine Ramsey Schulte

Robert W. Baird

CHF106.91→CHF110.96

Hold

―

Reiterated

02/06/26

Illumina price target raised to $137 from $132 at BairdIllumina price target raised to $137 from $132 at Baird

Unknown Analyst

Jefferies

Not Ranked

Jefferies

CHF87.47→CHF101.24

Hold

―

Reiterated

12/17/25

Jefferies Sticks to Its Hold Rating for Illumina (ILMN)

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Subbu Nambi

Guggenheim

CHF145.78→CHF161.98

Buy

―

Reiterated

06/29/26

Illumina price target raised to $200 from $180 at GuggenheimIllumina price target raised to $200 from $180 at Guggenheim

Eve Burstein

Bernstein

CHF149.83

Hold

―

Initiated

06/25/26

Illumina resumed with a Market Perform at BernsteinIllumina resumed with a Market Perform at Bernstein

Luke Sergott

Barclays

CHF98.81→CHF117.44

Sell

―

Assigned

06/24/26

Barclays Sticks to Their Sell Rating for Illumina (ILMN)

Casey Woodring

J.P. Morgan

CHF101.24→CHF149.83

Buy

―

Upgraded

06/10/26

Illumina upgraded to Overweight from Neutral at JPMorganIllumina upgraded to Overweight from Neutral at JPMorgan

Dan Leonard

RBC Capital

CHF137.68

Buy

―

Initiated

05/14/26

Illumina resumed with an Outperform at RBC CapitalIllumina resumed with an Outperform at RBC Capital

Michael Ryskin

Bank of America Securities

CHF68.84→CHF80.99

Sell

―

Reiterated

05/14/26

Bank of America Securities Sticks to Its Sell Rating for Illumina (ILMN)

Narumi Nakagiri

Daiwa

CHF125.53

Buy

―

Upgraded

05/14/26

Illumina upgraded to Outperform from Neutral at DaiwaIllumina upgraded to Outperform from Neutral at Daiwa

Patrick B Donnelly

Citi

CHF64.79→CHF76.94

Sell

―

Assigned

05/04/26

Illumina price target raised to $95 from $80 at CitiIllumina price target raised to $95 from $80 at Citi

David Westenberg

Piper Sandler

CHF137.68

Buy

―

Reiterated

05/01/26

Illumina (ILMN) Receives a Buy from Piper Sandler

Kyle Mikson CFA

Canaccord Genuity

CHF121.49→CHF113.39

Hold

―

Reiterated

05/01/26

Illumina price target lowered to $140 from $150 at CanaccordIllumina price target lowered to $140 from $150 at Canaccord

Daniel Arias

Stifel Nicolaus

CHF125.53

Buy

―

Reiterated

05/01/26

Stifel Nicolaus Keeps Their Buy Rating on Illumina (ILMN)

Vijay Kumar

Evercore ISI

CHF121.49→CHF125.53

Buy

―

Reiterated

05/01/26

Illumina price target raised to $155 from $150 at Evercore ISIIllumina price target raised to $155 from $150 at Evercore ISI

Daniel Brennan

TD Cowen

CHF95.3→CHF113.39

Hold

―

Reiterated

04/30/26

Analysts Offer Insights on Healthcare Companies: Illumina (NASDAQ: ILMN) and Cardinal Health (NYSE: CAH)

Catherine Ramsey Schulte

Robert W. Baird

CHF106.91→CHF110.96

Hold

―

Reiterated

02/06/26

Illumina price target raised to $137 from $132 at BairdIllumina price target raised to $137 from $132 at Baird

Unknown Analyst

Jefferies

Not Ranked

Jefferies

CHF87.47→CHF101.24

Hold

―

Reiterated

12/17/25

Jefferies Sticks to Its Hold Rating for Illumina (ILMN)

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

TRAXFirst Tracks Biotherapeutics Inc

EVMNEvommune, Inc.

MPLTMapLight Therapeutics, Inc.

MAZEMaze Therapeutics, Inc.

AAPGAscentage Pharma Group International Unsponsored ADR

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Illumina

3 Months

Patrick B DonnellyCiti

Success Rate

10/16 ratings generated profit

Average Return

+0.98%

Copying Patrick B Donnelly's trades and holding each position for 3 Months would result in 62.50% of your transactions generating a profit, with an average return of +0.98% per trade.

1 Year

Vijay KumarEvercore ISI

Success Rate

10/17 ratings generated profit

Average Return

+16.05%

Copying Vijay Kumar's trades and holding each position for 1 Year would result in 58.82% of your transactions generating a profit, with an average return of +16.05% per trade.

2 Years

Vijay KumarEvercore ISI

Success Rate

11/17 ratings generated profit

Average Return

+21.86%

Copying Vijay Kumar's trades and holding each position for 2 Years would result in 64.71% of your transactions generating a profit, with an average return of +21.86% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

ILU Analyst Recommendation Trends

Rating

Feb 26

Mar 26

Apr 26

May 26

Jun 26

Strong Buy

0

Buy

9

6

9

Hold

12

11

6

4

Sell

6

5

6

Strong Sell

1

0

total

28

27

22

18

19

In the current month, ILU has received 9 Buy Ratings, 4 Hold Ratings, and 6 Sell Ratings. ILU average Analyst price target in the past 3 months is 124.29.

Each month's total comprises the sum of three months' worth of ratings.

ILU Financial Forecast

ILU Earnings Forecast

Next quarter’s earnings estimate for ILU is $0.98 with a range of $0.96 to $1.01. The previous quarter’s EPS was $0.92. ILU beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year ILU has Performed in-line its overall industry.

ILU Sales Forecast

Next quarter’s sales forecast for ILU is $902.51M with a range of $894.18M to $910.06M. The previous quarter’s sales results were $870.95M. ILU beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year ILU has Performed in-line its overall industry.

ILU Stock Forecast FAQ

What is CH:ILU’s average 12-month price target, according to analysts?

Based on analyst ratings, Illumina’s 12-month average price target is 124.29.

What is CH:ILU’s upside potential, based on the analysts’ average price target?

Currently there's no upside potential for CH:ILU, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is Illumina a Buy, Sell or Hold?

Illumina has a consensus rating of Moderate Buy, which is based on 7 buy ratings, 3 hold ratings and 3 sell ratings.

What is Illumina’s share price target?

The average share price target for Illumina is 124.29. This is based on 13 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is $161.98 ,and the lowest forecast is $76.94. The average share price target represents N/A Increase from the current price of N/A.

What do analysts say about Illumina?

Illumina’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 13 Wall Streets Analysts.

How can I buy shares of Illumina?

To buy shares of CH:ILU, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.

Illumina (ILU) Stock Forecast & Price Target

ILU Analyst Ratings

ILU Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Illumina

ILU Analyst Recommendation Trends

ILU Financial Forecast

ILU Earnings Forecast

ILU Sales Forecast

ILU Stock Forecast FAQ

Detailed List of Analyst Forecasts